filename	patient_barcode	bcr_sample_uuid	histological_type	days_to_sample_procurement	path_confirm_report_attached	method_of_sample_procurement	other_method_of_sample_procurement	other_vessel_used	vessel_used	sample_prescreened	tumor_weight	country	tumor_nuclei_percent	tumor_necrosis_percent	days_to_pathology_review	path_confirm_tumor_nuclei_metrics	path_confirm_tumor_necrosis_metrics	path_confirm_diagnosis_matching	reason_path_confirm_diagnosis_not_matching	other_dx	history_of_neoadjuvant_treatment	consent_or_death_status	days_to_consent	burkitt_clinical_variant	ffpe_tumor_slide_submitted	site_of_disease	site_of_disease_description	site_of_disease_text	submitted_for_lce	digital_image_submitted	top_slide_submitted	File ID	Data Category	Data Type	Project ID	Case ID	Sample ID	Sample Type	id	md5	size	state	HRD	Telomeric AI	LST	HRD-sum	Cancer_type	annotation	HRDscore	HRDscore34
03c093c1-9198-4bb9-994b-b81871afeef6.htseq.counts	TCGA-HB-A43Z	A6BBEE06-44BF-446A-8D21-550AA6E71960	Leiomyosarcoma (LMS)	5	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	929	United States	70	5	35	YES	YES	YES	[Not Available]	"Yes, History of Synchronous/Bilateral Malignancy"	No	Consented	5	[Not Available]	Digital Image	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	NO	6471065e-e4f6-4ac0-aa9b-79c2f074b325	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-HB-A43Z	TCGA-HB-A43Z-01A	Primary Tumor	6471065e-e4f6-4ac0-aa9b-79c2f074b325	180a4734dc4c731e78d7d97fc8d05e4c	254893	released	14	26	15	55	Leiomyosarcoma-Uterus	uLMS	HRD-high	HRDhigh
0ee81f55-b068-4255-ac0a-8e91f9cb22d5.htseq.counts	TCGA-HS-A5N9	ECBC891E-ED99-4541-BDA5-EDE1F28ABA8A	Leiomyosarcoma (LMS)	-25	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	980	Canada	90	9	927	YES	YES	YES	[Not Available]	"Yes, History of Prior Malignancy"	No	Consented	-52	[Not Available]	Digital Image	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	NO	43e41c7f-269a-4ed0-8ba2-93e2dfc77309	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-HS-A5N9	TCGA-HS-A5N9-01A	Primary Tumor	43e41c7f-269a-4ed0-8ba2-93e2dfc77309	21cd9c6c66c60dd8d3d6b67a830e6c64	248021	released	2	26	12	40	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDhigh
2a29763d-bf90-4489-b26f-1f05375aa1ff.htseq.counts	TCGA-HB-A3L4	D2165554-A30A-49E9-8038-C9539D487A22	Leiomyosarcoma (LMS)	0	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	189	United States	100	0	707	YES	YES	YES	[Not Available]	No	No	Consented	-17	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	NO	YES	NO	fbf1653a-96a7-4600-b4af-28912e27db2d	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-HB-A3L4	TCGA-HB-A3L4-01A	Primary Tumor	fbf1653a-96a7-4600-b4af-28912e27db2d	595cd89346181b7f817605d2493e8c7c	249827	released	14	13	18	45	Leiomyosarcoma-Uterus	uLMS	HRD-high	HRDhigh
2e3c0a9e-ddd9-4034-ad3f-ceede555db4f.htseq.counts	TCGA-JV-A5VF	976AFD99-08BA-440D-8ECD-9918AE4279CB	Leiomyosarcoma (LMS)	0	YES	Incisional Biopsy	[Not Applicable]	[Not Applicable]	Cryovial	YES	211	United States	90	0	18	YES	YES	YES	[Not Available]	No	No	Consented	0	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	YES	e2aab053-be80-4530-949f-4e37aa9a1aa6	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-JV-A5VF	TCGA-JV-A5VF-01A	Primary Tumor	e2aab053-be80-4530-949f-4e37aa9a1aa6	2cec4bfbc332d8718e9f2a8132a46fd7	249882	released	11	12	12	35	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDhigh
3f2723f9-77e2-4b85-afc7-62f4ee68bfe6.htseq.counts	TCGA-N1-A6IA	AF8434CF-5C2F-48CC-B3AC-132DFB505DBD	Leiomyosarcoma (LMS)	0	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	144	United States	100	0	558	YES	YES	YES	Macrodissection performed at TSS to select for a region containing an acceptable TCGA diagnosis	No	No	Consented	-2	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	YES	c9185497-a822-4011-bbd9-289104e79d6f	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-N1-A6IA	TCGA-N1-A6IA-01A	Primary Tumor	c9185497-a822-4011-bbd9-289104e79d6f	859cb7153ed49389f94a319fbc083139	250795	released	6	21	14	41	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDhigh
4e7d2e2f-610e-4771-8585-a16ffefa8c4b.htseq.counts	TCGA-X6-A7WB	1857E1ED-2584-4B12-B889-791CAF08DC5E	Leiomyosarcoma (LMS)	34	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryomold	YES	1100	United States	95	1	736	YES	YES	YES	[Not Available]	No	No	Consented	50	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	YES	3d77867e-562d-4925-909c-0893b44a9150	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-X6-A7WB	TCGA-X6-A7WB-01A	Primary Tumor	3d77867e-562d-4925-909c-0893b44a9150	8981e3cc78907b91fe3dc5ac1842f172	254258	released	15	7	9	31	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDlow
56c85936-07f8-4171-aef2-fd867b863acc.htseq.counts	TCGA-IS-A3K6	BBDE8AF5-F8D9-4D21-BB26-6486435F0F5A	Leiomyosarcoma (LMS)	29	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cassette	YES	200	United States	99	0	4082	YES	YES	YES	[Not Available]	"Yes, History of Prior Malignancy"	No	Consented	21	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	NO	NO	YES	8a4ca930-d6a7-4b66-8836-a262f7f6c110	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-IS-A3K6	TCGA-IS-A3K6-01A	Primary Tumor	8a4ca930-d6a7-4b66-8836-a262f7f6c110	89d3190d61a657036f429bda62cc6201	251766	released	5	6	6	17	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDlow
5ecd8d47-e358-4486-bf06-5dbc35d6aa46.htseq.counts	TCGA-FX-A48G	CEEBA881-5A1D-4FDC-8C9D-D60B3FACECF2	Leiomyosarcoma (LMS)	0	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	65	United States	90	0	365	YES	YES	YES	[Not Available]	No	No	Consented	2	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	[Not Available]	YES	NO	5dd74d20-81cd-4f73-a508-d2865809a10a	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-FX-A48G	TCGA-FX-A48G-01A	Primary Tumor	5dd74d20-81cd-4f73-a508-d2865809a10a	f2dabfe49ac7cc36d89d08c439dbab77	247039	released	14	18	13	45	Leiomyosarcoma-Uterus	uLMS	HRD-high	HRDhigh
63c39b0f-2e8f-4ad1-a943-f58f10bd3a49.htseq.counts	TCGA-HS-A5NA	544D66C8-2E7B-4234-AEFD-DEB441E3B28E	Leiomyosarcoma (LMS)	-11	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	570	Canada	90	9	955	YES	YES	YES	[Not Available]	No	No	Consented	-36	[Not Available]	Digital Image	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	NO	033d33b6-1154-4a1a-b0f1-04381c6f99da	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-HS-A5NA	TCGA-HS-A5NA-01A	Primary Tumor	033d33b6-1154-4a1a-b0f1-04381c6f99da	8c7686d601e28da8e396ec874274a679	248452	released	10	12	8	30	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDlow
6e952a6c-3287-4478-a82d-fea3f36b0a9c.htseq.counts	TCGA-3B-A9I1	06990702-C200-403C-AD6F-5CB78A15BF55	Leiomyosarcoma (LMS)	18	YES	Surgical Resection	[Not Applicable]	Biospecimen Storage Bag	Other	YES	127	United States	100	5	66	YES	YES	YES	[Not Available]	No	No	Consented	11	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	YES	c4a1c83b-8bb1-49de-bb4b-f58676e94f84	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-3B-A9I1	TCGA-3B-A9I1-01A	Primary Tumor	c4a1c83b-8bb1-49de-bb4b-f58676e94f84	bb55f362b7118c81cf9bdea84f10506c	252847	released	7	17	12	36	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDhigh
803682f7-89c0-446c-87d4-c86131ad8e4b.htseq.counts	TCGA-JV-A75J	ED0E5F9D-7DF8-4AF8-9916-D30139A9B807	Leiomyosarcoma (LMS)	0	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	55	United States	80	5	74	YES	YES	YES	[Not Available]	No	No	Consented	0	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	YES	d8aa9a99-c9fe-4b73-8074-e00439ef359f	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-JV-A75J	TCGA-JV-A75J-01A	Primary Tumor	d8aa9a99-c9fe-4b73-8074-e00439ef359f	932cd9fc9461011a5184fefad660e893	253044	released	8	13	3	24	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDlow
8b82feac-4c40-4408-b13a-1a8a5830c200.htseq.counts	TCGA-KF-A41W	A60B467B-E29D-4AC0-A221-DAE30011A183	Leiomyosarcoma (LMS)	0	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	1077	United States	90	10	75	YES	YES	YES	[Not Available]	"Yes, History of Prior Malignancy"	No	Consented	0	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	NO	NO	YES	4e9b700a-89a8-4a14-a573-d3f8a2bfbf9f	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-KF-A41W	TCGA-KF-A41W-01A	Primary Tumor	4e9b700a-89a8-4a14-a573-d3f8a2bfbf9f	0b158d90ef54f21a6dd408e928225643	244239	released	19	25	13	57	Leiomyosarcoma-Uterus	uLMS	HRD-high	HRDhigh
93d76b56-2660-46b7-acfd-0afc04ec7901.htseq.counts	TCGA-IE-A4EH	988185CF-A54C-4335-A4AB-F59CE3A470EA	Leiomyosarcoma (LMS)	314	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	200	United States	90	0	342	YES	YES	YES	[Not Available]	"Yes, History of Synchronous/Bilateral Malignancy"	No	Consented	314	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	NO	NO	NO	78d672bc-25f5-44fe-986f-d968f985b1a8	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-IE-A4EH	TCGA-IE-A4EH-01A	Primary Tumor	78d672bc-25f5-44fe-986f-d968f985b1a8	1750ed06b85ff954f0d8bffda151644b	249148	released	11	15	8	34	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDhigh
951db72b-e8ae-45bb-9a2b-3ba452b9e111.htseq.counts	TCGA-WP-A9GB	4DF7599A-680C-452A-B472-2370B8F190A5	Leiomyosarcoma (LMS)	31	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	376	United States	90	5	610	YES	YES	YES	[Not Available]	No	No	Consented	31	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	YES	19bd2173-2e51-485e-9820-f469628fe184	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-WP-A9GB	TCGA-WP-A9GB-01A	Primary Tumor	19bd2173-2e51-485e-9820-f469628fe184	7ed6609a64c3d6f29c08d1cebd3f8d11	254797	released	15	18	29	62	Leiomyosarcoma-Uterus	uLMS	HRD-high	HRDhigh
98b10baf-a8e5-4269-a31c-a151737b3d5e.htseq.counts	TCGA-JV-A5VE	7328589C-0287-4784-83A6-4BD0CD072D1C	Leiomyosarcoma (LMS)	0	YES	Incisional Biopsy	[Not Applicable]	[Not Applicable]	Cryovial	YES	184	United States	95	0	20	YES	YES	YES	[Not Available]	No	No	Consented	0	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	YES	c86b0470-0a79-4411-84ac-d404a0947049	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-JV-A5VE	TCGA-JV-A5VE-01A	Primary Tumor	c86b0470-0a79-4411-84ac-d404a0947049	c99ebba80c8f0db62651ef5bab02ad14	252630	released	14	18	9	41	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDhigh
a6ac2caa-ba71-4520-a36e-6e790f468165.htseq.counts	TCGA-KD-A5QT	586F6A69-FCB9-422F-B71E-AA8B2354694F	Leiomyosarcoma (LMS)	0	YES	"Other Method, specify"	MRH/BSO	[Not Applicable]	Cryovial	YES	100	United States	90	0	861	YES	YES	YES	[Not Available]	No	No	Consented	0	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	YES	6bc8c44b-de7a-44e5-a1d2-94b68f146bee	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-KD-A5QT	TCGA-KD-A5QT-01A	Primary Tumor	6bc8c44b-de7a-44e5-a1d2-94b68f146bee	8c94743d326dd57439d32ad9d030c020	250926	released	7	10	8	25	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDlow
a83fc4d2-aad3-401c-820a-cd4519032be0.htseq.counts	TCGA-IW-A3M5	34B60937-76B3-401C-A8DD-3F78E2B20A38	Leiomyosarcoma (LMS)	0	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	150	United States	95	5	364	YES	YES	YES	[Not Available]	No	No	Consented	0	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	NO	NO	YES	5d8422df-2388-4118-963e-6cc7538f2e6f	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-IW-A3M5	TCGA-IW-A3M5-01A	Primary Tumor	5d8422df-2388-4118-963e-6cc7538f2e6f	8df181b9a75a2b07d25e9bba33b1ccb0	250295	released	7	24	7	38	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDhigh
a9984029-887a-4215-a013-5ce599588ba5.htseq.counts	TCGA-IS-A3K7	7254C2AC-D8AC-4D6E-B444-4CB5F8A6EB36	Leiomyosarcoma (LMS)	30	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cassette	YES	200	United States	99	0	3999	YES	YES	YES	[Not Available]	No	No	Consented	28	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	NO	NO	YES	e59e6cff-ec31-4284-b63b-bdf81a0477e1	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-IS-A3K7	TCGA-IS-A3K7-01A	Primary Tumor	e59e6cff-ec31-4284-b63b-bdf81a0477e1	82ea05f911e984884c925fffef5f94d8	249722	released	15	12	10	37	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDhigh
af1619c5-6441-4cf7-bb16-cd2be1473e5d.htseq.counts	TCGA-KD-A5QU	52254562-F812-4023-BB00-55E2D766EADB	Leiomyosarcoma (LMS)	37	YES	"Other Method, specify"	TAH/BSO	[Not Applicable]	Cryovial	YES	100	United States	99	0	699	YES	YES	YES	[Not Available]	No	No	Consented	37	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	YES	ff5c13bd-f0c2-4dc4-8554-0bf90bc6b144	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-KD-A5QU	TCGA-KD-A5QU-01A	Primary Tumor	ff5c13bd-f0c2-4dc4-8554-0bf90bc6b144	d4ea4751db7c3ac9d2d15446240643f3	254741	released	7	16	16	39	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDhigh
b0322292-c63d-4f22-8b9a-4f4adba47ae3.htseq.counts	TCGA-IW-A3M6	BCAEA097-8911-4503-8AF9-E7E0515D1529	Leiomyosarcoma (LMS)	0	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	100	United States	95	5	189	YES	YES	YES	[Not Available]	"Yes, History of Prior Malignancy"	No	Consented	0	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	NO	NO	YES	97729b96-026a-4679-8d9f-4b989a6e0ecf	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-IW-A3M6	TCGA-IW-A3M6-01A	Primary Tumor	97729b96-026a-4679-8d9f-4b989a6e0ecf	204a766b9503174b4a499e1c5e6e2808	250658	released	15	20	21	56	Leiomyosarcoma-Uterus	uLMS	HRD-high	HRDhigh
b1e26350-1636-4dc0-8180-e7ad086fa45c.htseq.counts	TCGA-X2-A95T	2DE5878A-85D4-4A26-9E7D-8D0834CB72EC	Leiomyosarcoma (LMS)	0	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryomold	YES	120	United States	100	0	1543	YES	YES	YES	[Not Available]	No	No	Consented	1548	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	YES	8216cca0-a8e6-4c02-ae49-4808a563c077	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-X2-A95T	TCGA-X2-A95T-01A	Primary Tumor	8216cca0-a8e6-4c02-ae49-4808a563c077	57812196c33b6c55db2eb245d2184cf5	253790	released	10	11	11	32	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDlow
bc079ef6-d481-4ee2-9365-b183444c4f75.htseq.counts	TCGA-IS-A3K8	F4D8A916-A0B5-4632-8E21-6A6D3EFB883B	Leiomyosarcoma (LMS)	0	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cassette	YES	200	United States	95	0	3506	YES	YES	YES	[Not Available]	"Yes, History of Prior Malignancy"	No	Consented	-6	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	NO	NO	YES	422bfae2-9b30-4c97-8419-2b2dfe5773ff	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-IS-A3K8	TCGA-IS-A3K8-01A	Primary Tumor	422bfae2-9b30-4c97-8419-2b2dfe5773ff	42aa2921b613fa30dbd1c14dce8bd84e	249277	released	4	3	0	7	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDlow
bffe7bae-47a4-43f0-b071-93ce7337d7fb.htseq.counts	TCGA-HS-A5N8	C91F6F45-EBFB-45CC-A0DD-9862B375336C	Leiomyosarcoma (LMS)	-18	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	900	Canada	70	9	679	YES	YES	YES	[Not Available]	No	No	Consented	-28	[Not Available]	Digital Image	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	NO	9e977a45-ee45-49c8-8501-58848d4fc74a	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-HS-A5N8	TCGA-HS-A5N8-01A	Primary Tumor	9e977a45-ee45-49c8-8501-58848d4fc74a	a8e4fd7b534d7fcef6124022bd54a0f9	253403	released	16	29	19	64	Leiomyosarcoma-Uterus	uLMS	HRD-high	HRDhigh
c364d724-8fa5-4590-bbec-0894925ced44.htseq.counts	TCGA-KD-A5QS	7B8B0BE7-184D-4334-88F3-58BF561CE055	Leiomyosarcoma (LMS)	-5	YES	"Other Method, specify"	TAH/BSO	[Not Applicable]	Cryovial	YES	100	United States	65	0.5	958	YES	YES	YES	[Not Available]	No	No	Consented	-5	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	[Not Available]	NO	YES	bf2f6ccc-2d8d-4ba4-8c16-ada936061b13	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-KD-A5QS	TCGA-KD-A5QS-01A	Primary Tumor	bf2f6ccc-2d8d-4ba4-8c16-ada936061b13	804814a288c7cd3234ec98330b92bc57	246418	released	17	33	30	80	Leiomyosarcoma-Uterus	uLMS	HRD-high	HRDhigh
e18f1492-00e7-4f95-85da-9cf0bd4ca229.htseq.counts	TCGA-IW-A3M4	F854DB6B-57CB-4DA7-9252-B2ADE22C2675	Leiomyosarcoma (LMS)	0	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	150	United States	100	0	2198	YES	YES	YES	[Not Available]	No	No	Consented	0	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	NO	NO	YES	c62a9a17-da02-4232-ad93-47d3c6f27601	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-IW-A3M4	TCGA-IW-A3M4-01A	Primary Tumor	c62a9a17-da02-4232-ad93-47d3c6f27601	4de13ed1d1d86918669b0d92604a5149	250713	released	8	4	5	17	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDlow
e3402ce9-c06b-48e2-b5f4-ba81d3e1dac7.htseq.counts	TCGA-FX-A76Y	7CC6EB42-FAC5-48C6-A2EE-5BC49D0B3F8F	Leiomyosarcoma (LMS)	0	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cryovial	YES	58	United States	90	0	89	YES	YES	YES	[Not Available]	No	No	Consented	2	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	[Not Available]	YES	NO	efff5fa4-2d0c-4660-8530-d46ffa45ad60	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-FX-A76Y	TCGA-FX-A76Y-01A	Primary Tumor	efff5fa4-2d0c-4660-8530-d46ffa45ad60	e9ac22955791065cf208ca0fac8d700d	254170	released	4	4	5	13	Leiomyosarcoma-Uterus	uLMS	HRD-low	HRDlow
eff0bfff-4b66-4fd1-9f5b-ceb3cf6c7c81.htseq.counts	TCGA-IS-A3KA	F8495459-CAF7-47CA-9B6A-7FE11FF1BA11	Leiomyosarcoma (LMS)	31	YES	Surgical Resection	[Not Applicable]	[Not Applicable]	Cassette	YES	200	United States	90	0	2707	YES	YES	YES	[Not Available]	No	No	Consented	20	[Not Available]	NO	Uterus	[Not Available]	[Not Available]	NO	NO	YES	78a5c302-4d3c-44b7-800e-a6a39f0997af	Transcriptome Profiling	Gene Expression Quantification	TCGA-SARC	TCGA-IS-A3KA	TCGA-IS-A3KA-01A	Primary Tumor	78a5c302-4d3c-44b7-800e-a6a39f0997af	117a0b148f268d70465f75b2c9bb1abb	249480	released	8	24	16	48	Leiomyosarcoma-Uterus	uLMS	HRD-high	HRDhigh